Net Cash Provided by (Used in) Financing Activities |
7.04M |
USD |
+46.2% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
10.6M |
shares |
+46.8% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.03M |
USD |
-44% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
10.3M |
USD |
-33.2% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.53M |
USD |
-9.55% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
72.2M |
USD |
-15.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
72.2M |
USD |
-15.3% |
Q4 2023 |
FY 2023 |
Depreciation |
13.1M |
USD |
-61.4% |
Q2 2024 |
Q2 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-5.57M |
USD |
+44.5% |
Q2 2024 |
Q2 2024 |
Property, Plant and Equipment, Gross |
59.4M |
USD |
-21.7% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
40.1M |
USD |
-30.8% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
328M |
USD |
+6.66% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
2.6M |
USD |
-13.3% |
Q2 2024 |
Q2 2024 |
Interest Expense |
1.8M |
USD |
-50% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |